Yahoo Home 
Anjalee Khemlani is a reporter at Yahoo Finance covering all things business, with a focus on health care. Khemlani has previously worked for a variety of media organizations that include startup digital, legacy daily news, international broadcast and local radio. Her most recent position was as a managing editor of ROI-NJ in New Jersey.
Yahoo FinanceModerna's Bancel defends COVID-19 vaccine price at Sanders hearing
Moderna's CEO Stéphane Bancel faced off with Sen. Bernie Sanders and others of the Senate HELP committee to defend raising the COVID vaccine price for the commercial market.
- Yahoo Finance
Moderna CEO faces Sen. Sanders in COVID-19 vaccine pricing hearing Wednesday
Moderna CEO Stéphane Bancel is set to face Sen. Bernie Sanders to defend the company's fast growth and planned price hike of its COVID-19 vaccine.
- Yahoo Finance
Cue Health's new lineup of tests joins growing at-home collection market
Cue Health is one of the last test makers standing that rode the Covid-19 pandemic wave. It announced a slate of new tests that could boost revenue.
- Yahoo Finance
CMS releases 'bombshell' guidance draft of Medicare drug price negotiations
Medicare issues draft guidance for drug price negotiation
- Yahoo Finance
Medicare identifies drug makers that will owe penalties for raising prices on 27 drugs faster than rate of inflation
The Biden administration is making good on promises to help lower drug costs, though the impact is largely for Medicare patients.
- Yahoo Finance
Weight Watchers CEO on diabetes drugs for weight loss: 'There's been a lot of misinformation and misuse'
Weight Watchers sees an opportunity to be a guide for chronic disease management in weight loss space.
- Yahoo Finance
Walgreens internal memo says it is following the law on abortion pill distribution
Walgreens faces backlash over misperception of its intent to sell abortion pill in some states.
- Yahoo Finance
Health exec: 'Publicly traded entities don’t necessarily understand clinical culture'
CVS acquiring Oak Street and Amazon acquiring One Medical are just the latest moves in retail health. But they could have significant future impact.
- Yahoo Finance
Novavax to pause RSV vaccine trial, assess pipeline
Novavax warns of uncertain 2023 outlook as COVID-19 market turns commercial and new CEO calls for pipeline assessment.
- Yahoo Finance
Pfizer favored over Merck for Seagen acquisition: SVB analyst
Seagen is once again an acquisition target this year, pursued by yet another partner, Pfizer. Last year, a deal with Merck fell through over price disagreements.
- Yahoo Finance
Why you should care about CVS acquiring Oak Street Health
CVS is becoming a dominant player beyond pharmacies. It's planned acquisition of Oak Street Health furthers that view.
- Yahoo Finance
COVID is 'pretty much out of the models' for pharma companies: Wells Fargo analyst
Companies whose businesses were buoyed or boosted by Covid product demand are facing a cliff in 2023, and will have to pivot to more traditional strategies.
- Yahoo Finance
Amazon's new RxPass is 'incremental step' in its foray into health care: Analyst
Amazon announces a new drug pass for Prime members.
- Yahoo Finance
Carbon Health poised for growth despite slowdown in investor market
Carbon Health had to slow its growth in response to a cooler market for health care investment this year.
- Yahoo Finance
Outgoing Novavax CEO: 'The government has to get out of the way'
Novavax (NVAX) is readying its forces to be a fully commercially-licensed company by the end of 2023, with a strong balance sheet and the workforce to achieve the endpoint.
- Yahoo Finance
'We agree that vaccines should be free': Moderna's Noubar Afeyan
Moderna will set the price of its COVID-19 vaccine at the same level as Pfizer when the shots hit the commercial market this year.
- Yahoo Finance
How Walgreens will convert pharmacy space to grow a clinical trial business
Walgreens is competing with CVS and Walmart to enter the clinical trial space at a time when attention on the industry has spiked amid concerns of a lack of diversity of trial participants.
- Yahoo Finance
'You have to now design and manufacture faster,' AI exec says
Since the start of the pandemic, the pharmaceutical industry's reliance on overseas manufacturing has been in the spotlight.
- Yahoo Finance
Pharmacies limit the purchase of kids' meds. How bad are the shortages?
Children's fever and pain reductio medications are in short supply, forcing major retail pharmacies to limit purchases.
- Yahoo Finance
Personalized cancer vaccine results are a 'home run': Moderna CEO
Moderna and Merck released preliminary results of a personalized cancer vaccine for late-stage melanoma patients.